OTC:RAPH | Profit Breakdown | Raphael Pharmaceutical Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$199,000.00-$223,000.00
2026-03-31-$223,000.00-$229,000.00
2025-12-31-$254,000.00-$273,000.00
2025-09-30-$251,000.00-$255,000.00
2025-06-30-$315,000.00-$322,000.00
2025-03-31-$425,000.00-$429,000.00
2024-12-31-$394,000.00-$395,000.00
2024-09-30-$319,000.00-$326,000.00
2024-06-30-$249,000.00-$248,000.00
2024-03-31-$547,000.00-$550,000.00
2023-12-31$74,000.00$62,000.00
2023-09-30-$729,000.00-$725,000.00
2023-06-30-$419,000.00-$417,000.00
2023-03-31-$258,000.00-$264,000.00
2022-12-31-$1.1M-$1.1M
2022-09-30-$1.43M-$1.44M
2022-06-30-$612,000.00-$627,000.00
2022-03-31-$175,000.00-$185,000.00
2021-12-31-$574,000.00-$566,000.00
2021-09-30-$418,000.00-$416,000.00
2021-06-30-$385,000.00-$387,000.00
2021-03-31-$252,000.00-$255,000.00
2020-12-31-$227,000.00-$230,000.00
2020-09-30-$235,000.00-$243,000.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$1.25M-$1.28M
2024-12-31-$1.51M-$1.52M
2023-12-31-$1.33M-$1.34M
2022-12-31-$3.32M-$3.36M
2021-12-31-$1.63M-$1.62M
2020-12-31-$706,000.00-$718,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.